genOway Société anonyme (ALGEN.PA)

EUR 3.92

(0.0%)

Net Income Summary of genOway Société anonyme

  • genOway Société anonyme's latest annual net income in 2023 was 1.56 Million EUR , up 101.55% from previous year.
  • genOway Société anonyme's latest quarterly net income in 2024 Q2 was 706 Thousand EUR , down 0.0% from previous quarter.
  • genOway Société anonyme reported an annual net income of 777.75 Thousand EUR in 2022, up 341.09% from previous year.
  • genOway Société anonyme reported an annual net income of -322.59 Thousand EUR in 2021, up 53.06% from previous year.
  • genOway Société anonyme reported a quarterly net income of 1.56 Million EUR for 2023 FY, up 101.55% from previous quarter.
  • genOway Société anonyme reported a quarterly net income of 1.01 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Net Income Chart of genOway Société anonyme (2023 - 2009)

Historical Annual Net Income of genOway Société anonyme (2023 - 2009)

Year Net Income Net Income Growth
2023 1.56 Million EUR 101.55%
2022 777.75 Thousand EUR 341.09%
2021 -322.59 Thousand EUR 53.06%
2020 -687.3 Thousand EUR 33.69%
2019 -1.03 Million EUR -281.31%
2018 571.64 Thousand EUR -70.4%
2017 1.93 Million EUR 231.67%
2016 582.23 Thousand EUR 1416.71%
2015 38.38 Thousand EUR 44.43%
2014 26.57 Thousand EUR -89.82%
2013 261.03 Thousand EUR 174.14%
2012 -352.1 Thousand EUR -170.09%
2011 502.32 Thousand EUR -10.47%
2010 561.09 Thousand EUR 380.89%
2009 116.67 Thousand EUR 0.0%

Peer Net Income Comparison of genOway Société anonyme

Name Net Income Net Income Difference
ABIONYX Pharma SA -3.51 Million EUR 144.559%
ABIVAX Société Anonyme -147.74 Million EUR 101.061%
Adocia SA -21.16 Million EUR 107.407%
Aelis Farma SA -5.07 Million EUR 130.87%
Biophytis S.A. -17.02 Million EUR 109.207%
Advicenne S.A. -7.03 Million EUR 122.295%
IntegraGen SA -171.39 Thousand EUR 1014.577%
Medesis Pharma S.A. -3.95 Million EUR 139.59%
Neovacs S.A. -8.74 Million EUR 117.929%
NFL Biosciences SA -3.74 Million EUR 141.852%
Plant Advanced Technologies SA 79.16 Thousand EUR -1880.036%
Quantum Genomics Société Anonyme -3.17 Million EUR 149.436%
Sensorion SA -22.06 Million EUR 107.105%
Theranexus Société Anonyme -6.82 Million EUR 122.958%
TME Pharma N.V. -6.73 Million EUR 123.272%
Valbiotis SA -7.36 Million EUR 121.275%
TheraVet SA -1.57 Million EUR 199.801%
Valerio Therapeutics Société anonyme -20.34 Million EUR 107.705%
argenx SE -272.91 Million EUR 100.574%
BioSenic S.A. -28.77 Million EUR 105.447%
Celyad Oncology SA -8.44 Million EUR 118.556%
DBV Technologies S.A. -67.26 Million EUR 102.33%
Galapagos NV 211.69 Million EUR 99.26%
Genfit S.A. -28.89 Million EUR 105.425%
GeNeuro SA -14.75 Million EUR 110.623%
Hyloris Pharmaceuticals SA -15.38 Million EUR 110.192%
Innate Pharma S.A. -7.57 Million EUR 120.708%
Inventiva S.A. -110.42 Million EUR 101.42%
MaaT Pharma SA -19.71 Million EUR 107.95%
MedinCell S.A. -25.03 Million EUR 106.261%
Nanobiotix S.A. -39.7 Million EUR 103.949%
Onward Medical N.V. -36.18 Million EUR 104.333%
Oryzon Genomics S.A. -3.35 Million EUR 146.752%
OSE Immunotherapeutics SA -23 Million EUR 106.815%
Oxurion NV -18.96 Million EUR 108.264%
Pharming Group N.V. -9.75 Million EUR 116.067%
Poxel S.A. -35.09 Million EUR 104.467%
GenSight Biologics S.A. -26.22 Million EUR 105.979%
Transgene SA -22.32 Million EUR 107.021%
Financière de Tubize SA 88.15 Million EUR 98.222%
UCB SA 343 Million EUR 99.543%
Valneva SE -101.42 Million EUR 101.545%
Vivoryon Therapeutics N.V. -28.34 Million EUR 105.531%